CV First — The Expanding Role of Semaglutide in Obesity and ASCVD, Novo Nordisk Scientific Evening, 28.8 at 18:00, Spatenhaus at the opera, Munich

Novo Nordisk Scientific Evening — CV First: The Expanding Role of Semaglutide in Obesity and ASCVD
28.8
18:00

Spatenhaus at the opera
Residenzstasse 12, 8033 Munchen, Germany

Speakers

  • Prof. Shlomi Matetzky

    Prof. Shlomi Matetzky

    Sheba

  • Prof. Michal Laufer-Perl

    Prof. Michal Laufer-Perl

    Sourasky

  • Prof. Sa'ar Minha

    Prof. Sa'ar Minha

    Shamir

Registration for the event

Novo Nordisk

Novo Nordisk Israel | 1 Atir Yeda Street, 5th Floor, Kfar Saba 4464301, Israel | Phone no. 09-7630444

נובו נורדיסק ישראל | עתיר ידע 1, קומה 5, כפר סבא 4464301 ישראל | טלפון 09-7630444

IL26SEMO00250